Uncategorized
VIDEO: Study shows Omidria reduces need for pupillary expansion devices in cataract surgery
NEW ORLEANS — At the American Society of Cataract and Refractive Surgery meeting, Denise Visco, MD, discusses a retrospective study showing that use of Omidria, a 1% phenylephrine and 0.3% ketorolac agent from Omeros, in the balanced salt solution bottle during cataract surgery reduced the need for pupillary expansion devices in small pupil cases compared with use of epinephrine.